Surrey Heartlands

Joint Formulary & PAD

Dornase alfa - Intrapleural fibrinolysis

You are here : Home > Formulary Search > Dornase alfa - Intrapleural fibrinolysis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Nebules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important

For intrapleural use.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Dornase alfa
Indication :
Intrapleural fibrinolysis
Group Name :
Keywords :
Empyema
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Dornase alfa is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Intrapleural fibrinolysis.

Committee Recommendations (1)

06 Nov 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.